Ian Schnadig, MD
Medical Oncology, Hematology
Primary Location
West Cancer Center
12123 SW 69th Avenue,
Tigard, OR 97223
View Location Information
Phone Number
Sub-Specialties
- Adrenal Cancer
- Bladder Cancer
- Blood Cancers
- Blood Disorders
- Hematologic Malignancies
- Kidney Cancer
- Penile Cancer
- Prostate Cancer
- Testicular Cancer
Medical School
Doctor of Medicine, Rush University, Chicago, IL
Residency
Internal Medicine, Oregon Health & Sciences University, Portland, OR
Fellowship
Hematology/Oncology, Oregon Health & Sciences University, Portland, OR
Board Certification
- Medical Oncology
- Hematology
Special Interests
- Principal Investigator –Genitourinary Cancer & Supportive Care Studies
- Genitourinary (GU) malignancies
- General adult oncology
- Hematology
Affiliations
- Chief Medical Officer, Compass Oncology
- Prostate Cancer Physician Advocate Volunteer for US Too International
- Site Principal Investigator, ECOG Trials, Legacy Health
- Member, US Oncology GU National Research Committee
- GU Chair, Pathways Task Force, Pharmacy and Therapeutics Committee, McKesson
- American Society of Clinical Oncology (ASCO)
- American Society of Hematology (ASH)
- Southwest Oncology Group (SWOG)
Biography
Dr. Schnadig was named one of Portland's Top Medical Providers 2024 by Portland Monthly Magazine.
Dr. Schnadig was named one of Portland's Top Medical Providers 2023 by Portland Monthly Magazine.
Dr. Schnadig was named one of Portland's Top Medical Providers 2021 by Portland Monthly Magazine.
Dr. Schnadig was named one of Portland's Top Medical Providers 2020 by Portland Monthly Magazine.
Dr. Schnadig was named one of Portland's Top Docs of 2018 by Portland Monthly Magazine.
Dr. Schnadig specializes in genitourinary (GU) malignancies, general adult oncology and hematology. He is very active in The US Oncology Research Network, serving as a member of the national GU Research Committee and as principal investigator for many Phase II and Phase III studies. As GU Chair of the US Oncology Pathways Task Force, he is responsible for developing GU cancer treatment guidelines for physicians nationally. These facts speak to Dr. Schnadig’s practice philosophy of applying the most current and innovative thinking to help patients choose therapies and clinical trials targeted to their specific tumor characteristics.
Despite this busy schedule, Dr. Schnadig finds time to enjoy the pleasures of Pacific Northwest living including cycling, running and camping. He enjoys spending time with his wife and two children and volunteers at his son’s elementary school.